Pyrazolam

$175.00$2,000.00

Clear

 Pyrazolam

Pyrazolam is a water soluble derivative of benzodiazepine. Its IUPAC name is 8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine having molecular formula – C16H12BrN5 and molecular mass of 354.2 g/mol. It is used as a leading chemical for the purpose of research by educational institutions, laboratories and scientists. However, there are certain amazing facts related to Pyrazolam chemical that you must know as a member of research community.

Pyrazolam is a benzodiazepine derivative originally developed by a team led by Leo Sternbach at Hoffman-La Roche in the 1970s, and subsequently “rediscovered” and sold as a designer drug starting in 2012.

Pyrazolam has structural similarities to alprazolam and bromazepam. Unlike other benzodiazepines, pyrazolam does not appear to undergo metabolism, instead being excreted unchanged in the urine. It is most selective for the α2 and α3 subtypes of the GABAA receptor.

Pyrazolam is a benzodiazepine derivative originally developed by a team led by Leo Sternbach at Hoffman-La Roche in the 1970s, and subsequently “rediscovered” and sold as a designer drug starting in 2012.

Pyrazolam has structural similarities to alprazolam and bromazepam. Unlike other benzodiazepines, pyrazolam does not appear to undergo metabolism, instead being excreted unchanged in the urine. It is most selective for the α2 and α3 subtypes of the GABAA receptor.

Legal Status

United Kingdom
In the UK, pyrazolam has been classified as a Class C drug by section 5 of the May 2017 amendment to The Misuse of Drugs Act 1971 along with several other designer benzodiazepine drugs.

See also Pyrazolam

List of benzodiazepine designer drugs

References of Pyrazolam

US 3954728, “Preparation of triazolo benzodiazepines and novel compounds”
Moosmann, B.; Hutter, M.; Huppertz, L. M.; Ferlaino, S.; Redlingshöfer, L.; Auwärter, V. (July 2013). “Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine”. Forensic Toxicology. 31 : 263–271. doi:10.1007/s11419-013-0187-4.
Bjoern Moosmann; Leslie A King; Volker Auwärter (June 2015). “Designer benzodiazepines: A new challenge”. World Psychiatry. 14 : 248. doi:10.1002/wps.20236. PMC 4471986. PMID 26043347.
Madeleine Pettersson Bergstrand; Anders Helander; Therese Hansson; Olof Beck (2016). “Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays”. Drug Testing and Analysis. 9 (4): 640–645. doi:10.1002/dta.2003. PMID 27366870.
Høiseth, Gudrun; Tuv, Silja Skogstad; Karinen, Ritva (2016).

Pyrazolam

25g, 50g, 100g, 250g, 500g, 1kg

Reviews

There are no reviews yet.

Be the first to review “Pyrazolam”

Your email address will not be published. Required fields are marked *

error: Content is protected !!